glp 1 alzheimers Popular obesity drug fails in hotly anticipated Alzheimer's trials | Science Coveted GLP-1 Drugs Show Early

Description

AnnualSave 47% Discounted annual rate Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Monthly Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Ad-Free Premium ad-free reading Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Already have an account

This was not straightforward and took several years to achieve

A major clinical trial with 3,500 participants showed that semaglutide reduces disease progression by 24% and lowers the risk of kidney failure and cardiovascular death by 5%

However, Judge Pittman ruled that the agency acted within its discretion, citing its evaluation of supply and demand data, including public remarks made by Novo Nordisks CEO about access challenges